Takeda Pharmaceutical Ties Up with US Start-Up in T-Cell Cancer Therapy Jan. 18, 2017 Takeda Pharmaceutical Co. Ltd. (TYO:4502) announced on Jan. 12 that it has entered into an agreement to collaborate with Maverick…... Please subscribe to read the full story. Subscribe Free Trial